[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100648370":3},{"organization":4,"armGroups":7,"interventions":20,"overallOfficials":31,"centralContacts":35,"locations":41,"responsibleParty":60,"collaborators":26,"id":63,"slug":64,"hasResults":65,"nctId":66,"briefTitle":67,"officialTitle":68,"acronym":26,"eligibilityCriteria":69,"healthyVolunteers":65,"sex":70,"minAge":71,"maxAge":26,"enrollmentInfo":72,"targetDuration":26,"studyType":75,"phases":76,"briefSummary":78,"conditions":79,"keywords":82,"overallStatus":90,"whyStopped":26,"lastUpdateSubmitDate":91,"lastUpdatePostDateStruct":92,"startDateStruct":95,"completionDateStruct":96,"leadSponsor":98,"locationsCount":99},{"fullName":5,"class":6},"The University of Hong Kong","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Intervention group","EXPERIMENTAL","POC-cHbA1c + vHbA1c",[13],"Diagnostic Test: POC-cHbA1c",{"label":15,"type":16,"description":17,"interventionNames":18},"Control group","ACTIVE_COMPARATOR","Fingerstick RBG + vHbA1c",[19],"Diagnostic Test: Fingerstick RBG",[21,27],{"type":22,"name":23,"description":24,"armGroupLabels":25,"otherNames":26},"DIAGNOSTIC_TEST","POC-cHbA1c","Research staff will use quality-certified POC HbA1c devices to perform finger-prick capillary HbA1c testing for participants. Testing will be completed on site and results will be provided immediately.",[9],null,{"type":22,"name":28,"description":29,"armGroupLabels":30,"otherNames":26},"Fingerstick RBG","Research staff will use standardised glucometers and test strips to measure fingerstick random blood glucose. Test results will be provided on site.",[15],[32],{"name":33,"affiliation":5,"role":34},"William Chi Wai Wong, MD","PRINCIPAL_INVESTIGATOR",[36],{"name":37,"role":38,"phone":39,"phoneExt":26,"email":40},"Levon Yongle Zhan, PhD","CONTACT","852-25185656","levon@hku.hk",[42],{"facility":43,"status":26,"city":44,"state":45,"zip":46,"country":47,"countryCode":48,"cosmosGeoPoint":49,"geoPoint":54,"contacts":55},"The First People's Hospital of Dali","Dali","Yunnan","671000","China","CN",{"type":50,"coordinates":51},"Point",[52,53],100.21229,25.58474,{"lat":53,"lon":52},[56],{"name":57,"role":38,"phone":58,"phoneExt":26,"email":59},"Libo Yang, BMed","0872-2121378","448925216@qq.com",{"type":34,"investigatorFullName":61,"investigatorTitle":62,"investigatorAffiliation":5,"oldNameTitle":26,"oldOrganization":26},"William Chi Wai Wong","Clinical Professor","100648370","point-of-care-capillary-hba1c-testing-for-type-2-diabetes-screening-among-at-risk-individuals-in-rural-dali-china-100648370",false,"NCT07718867","Point-of-care Capillary HbA1c Testing for Type 2 Diabetes Screening Among At-risk Individuals in Rural Dali, China","Effectiveness and Cost-Effectiveness of Point-of-care Capillary HbA1c Testing for Type 2 Diabetes Screening Among At-risk Individuals in Rural Dali, Yunnan, China: A Cluster Randomised Controlled Trial","Inclusion Criteria:\n\n* Aged 18 years or above;\n* Permanent residents of Dali City who have lived locally for at least six consecutive months;\n* Registered as rural residents;\n* No known history of diabetes;\n* Meet at least one of the high-risk criteria for T2DM specified in the Chinese Guidelines for the Prevention and Treatment of Diabetes issued by the Chinese Diabetes Society;\n* Able to understand the study information and provide written informed consent.\n\nExclusion Criteria:\n\n* Known history of T2DM or currently receiving glucose-lowering treatment;\n* HbA1c testing with a clear result within the past three months, or completion of standardised diabetes screening within the past six months;\n* Pregnant or breastfeeding at the time of recruitment;\n* Active thyroid disease or other active endocrine disorders at recruitment, such as Cushing's syndrome or acromegaly;\n* Known haemoglobinopathy, severe anaemia, recent acute blood loss, or history of blood transfusion or blood donation within the past three months;\n* Currently receiving treatment that may substantially affect interpretation of HbA1c, such as erythropoietin therapy or recent high-dose iron therapy.","ALL","18 Years",{"count":73,"type":74},720,"ESTIMATED","INTERVENTIONAL",[77],"NA","This project aims to compare Point-of-care capillary HbA1c (POC-cHbA1c) testing and fingerstick random blood glucose (RBG) testing in terms of type 2 diabetes detection rate and cost-effectiveness, in order to optimise current screening strategies for rural populations at high risk of diabetes in rural Dali, China, and to improve treatment adherence and self-management among people with diabetes.",[80,81],"Type 2 Diabetes","Pre-diabetes",[83,84,85,86,87,88,89],"POCT","HbA1c","Diabetes screening","Effectiveness","Cost-effectiveness","Rural China","Cluster randomised controlled trial","NOT_YET_RECRUITING","2026-07-25",{"date":93,"type":94},"2026-07-28","ACTUAL",{"date":93,"type":74},{"date":97,"type":74},"2027-12-30",{"name":5,"class":6},1]